The randomization procedure in the Canadian National Breast Screening Study (NBSS) is
assessed in this issue (see pages 193 to 199) by Drs. John C. Bailar III and Brian …

Most analysts agree that screening women for breast cancer can reduce the death rate by at
least 25% to 30%. In 1993 the National Cancer Institute created a great deal of confusion …

Background: This systematic review is an update of the evidence since the 2001 Canadian
Task Force recommendations on breast cancer screening. Purpose: A decision was made to …

Multiple large-scale, randomized controlled trials throughout the world have demonstrated
screening mammography significantly reduces a woman's risk of dying from breast cancer …

Importance Patients need to consider both benefits and harms of breast cancer screening.
Objective To systematically synthesize available evidence on the association of …

Background Screening with mammography has been shown by randomized controlled trials
to reduce breast cancer mortality in women aged 40 to 74 years. Estimates from …

Breast cancer is still a major public health issue worldwide; according to present estimates,
1 million women will be diagnosed with breast cancer this year. There are no longer any …

Randomised controlled trials showed that breast cancer screening by mammography
reduces breast cancer mortality in women over age 50 by 25–30%. However, it was not …

Arguments over the credibility of the randomized screening mammography trials are red
herrings. The overall results of the trials suggest that screening very likely reduces breast …

Screening mammography has been shown to decrease breast cancer deaths through
randomized controlled trials. However, there remains significant debate surrounding the …